ARCHIVES

Celgene Signs CRADA With NCI For Development Of CDC-501.

This article is from The Cancer Letter archive.

Vol. 26 No. 26 | June 30, 2000

Download PDF Visit The Full Archive

Related Articles

FDA Accepts Advisory Committee’s Recommendations On NDA, Labeling

October 26, 1979

ASCO Strategic Plan Seeks To Increase Value to Members, Public

May 24, 2002

In Brief: McDonnell Foundation Selects Five For Awards; James Benson Is Named Interim FDA Head

November 24, 1989

New NCAB Weak In Grant Reviews, Confused By Issues

December 10, 1982

Growing Number Of New Research Ideas Create NCI Dilemma; How to Fund Them With A Flat Budget

October 1, 1982

In Brief: appropriations Approved; Grants, contracts May Flow Unimpeded; NCI Positions An Issue

December 16, 1977